I-RESPOND EVALUATION OF IRBESARTAN (WITH OR WITHOUT HCTZ) IN IMPROVING INSULIN SENSITIVITY IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME
Mark Identification

I-RESPOND EVALUATION OF IRBESARTAN (WITH OR WITHOUT HCTZ) IN IMPROVING INSULIN SENSITIVITY IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME

Serial Number

78902550

Filing Date

Jun 7, 2006

Registration Date

Apr 22, 2008

Trademark by

SANOFI

Classification Information

Clinical research in the field of hypertension and anti-hypertensive pharmaceuticals; medical and scientific research, namely, conducting clinical trials for anti-hypertensive pharmaceuticals

Computer and Scientific